Medtronic Inc. (NYSE:MDT) launched the first healthcare mobile app to work with its implanted cardiac medical devices and has plans to spread beyond Apple products into other mobile platforms.
Heart news: AtriCure sees big potential in ‘hybrid’ atrial fibrillation procedure
Cardiac medical device maker AtriCure Inc.’s (NSDQ:ATRC) sees big opportunity in a new "hybrid" procedure that treats atrial fibrillation with a combination of ablation from inside and outside of the heart.
FDA: Agency has included industry perspective on 510(k) review
On Thursday, Sen. Al Franken (D-Minn.) sent a letter to Dr. Jeffrey Shuren, director at the Center for Devices & Radiological Health at the U.S. Food & Drug Administration, that urged the agency to include industry input on any recommendations the Institute of Medicine makes about changes to the 510(k) process.
St. Jude Medical’s migraine treatment: Good for Europe, but not the US?
St. Jude Medical (NYSE:STJ) wanted to show the world last week that its new chronic migraine treatment was good enough to win regulatory approval.
Sen. Franken to Shuren: Get industry input before changing 510(k) system
St. Jude touts results of migraine treatment studies
An analyst described the results of St. Jude Medical’s (NYSE:STJ) clinical trial of its new neuromodulation product to treat chronic migraine as "impressive."
3M counters sabotage charge with blackmail lawsuit
3M Co. (NYSE:MMM) came out swinging against two U.K. firms that launched a lawsuit against the St. Paul, Minn. company for allegedly sabotaging a technology it acquired from that firm.
Mayo Clinic’s precedent-setting patent violation case heads to the Supreme Court
The nation’s highest court has agreed to hear a patent violation case brought by a California diagnostic firm against the Mayo Clinic.
In accepting the case, the high court will decide which diagnostic medical tests can be patented. Prometheus Labs is the owner of the patents, which it claimed, were infringed upon by Mayo.
Students from China work with Minnesota University to develop med tech
Impact of Cordis exit from Cypher stents on SurModics not severe
St. Jude Medical’s subsidiary sues European company again
St. Jude’s AGA Medical subsidiary has filed two new lawsuits against an European company that it has been tussling with since 2006.
The Little Canada, Minn.-based medical device conglomerate announced Thursday that it filed lawsuits against Occlutech, which develops cardiac occlusion devices and other vascular implants, in a German and U.K. court.